Antiplatelet effect of lonchocarpin and derricin isolated from Lonchocarpus sericeus

Pharmaceutical Biology

Volumn 43, Issue 8, 2005, Pages 726-731

  Fontenele, J B ^a   Leal, L K A M ^a   Ferreira, M A D ^a   Silveira, E R ^a   Viana, G S B ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Derricin; Lonchocarpin; Lonchocarpus sericeus; Pentoxifylline; Phosphodiesterase; Platelet aggregation

Indexed keywords

ADRENALIN; ARACHIDONIC ACID; ARGININE; CHALCONE DERIVATIVE; COLLAGEN; CYCLIC AMP; LONCHOCARPIN; LONCHOCARPUS SERICEUS EXTRACT; PLANT EXTRACT; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FRACTIONATION; HUMAN; HUMAN CELL; LONCHOCARPUS SERICEUS; MEDICINAL PLANT; THROMBOCYTE AGGREGATION;

FABACEAE; LONCHOCARPUS SERICEUS;

EID: 30344482870     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200500387406     Document Type: Article

References (37)

1. Anfonssí G, Russo I, Massuco P, Mattiello L, Perna P, Tassone F, Trovati M (1999): L-Arginine modulates aggregation and intracellular cyclic 3′,5′-guanosine monophosphate levels in human platelets: Direct effect and interplay with antioxidative thiol agent. Thromb Res 94: 307-316.
2. Born GVR, Cross MJ (1963): The aggregation of blood platelet. J Physiol 168: 178-195.
3. Brecher G, Cronkite EP (1950): Morphology and enumeration of human blood platelets. J Appl Physiol 3: 365-372.
4. Cunha GMA, Bezerra PJP, Saldanha MDD, Cavalcante MC, De-Bruin VMS, Viana GSB (2000): Pentoxifylline improves learning and memory in glutamate-lesioned rats. Pharmacol Biochem Behav 66: 687-694.
5. Cunha GMA, Fontenele JB, Nobre-Júnior HV, Martinsde-Souza FC, Silveira ER, Nogueira NAP, Moraes MO, Viana GSB, Costa-Lotufo LV (2003): Cytotoxic activity of chalcones isolated from Lonchocarpus sericeus (Poir.) Kunth. Phytother Res 17: 155-159.
6. De la Cruz JP, Romero MM, Sanchez P, Sanchez de la Cuesta F (1993): Antiplatelet effect of pentoxifylline in human whole blood. Gen Pharmacol 24: 605-609.
7. Elbein AD, Mitchell M, Sanford BA, Fellows LE, Evans SV (1984): The pyrrolidine alkaloid, 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine, inhibits glycoprotein processing. J Biol Chem 259: 12409-12413.
8. El-Subbagh HI, Abu-Zaid SM, Mahran MA, Bradia FA, Al-Obaid AM (2000): Synthesis and biological evaluation of certain alpha, beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents. J Med Chem 43: 2915-2921.
9. Fang N, Casida JE (1999): Cube resin insecticide: Identification and biological activity of 29 rotenoid constituents. J Agric Food Chem 47: 2130-2136.
10. Fontenele JB, Cardoso-De-Assis RK, Silveira ER, Viana GSB (2001): Analgesic effect of hexane fraction from roots of Lonchocarpus sericeus. Pharm Biol 39: 429-434.
11. Fuster V, Badimon JJ, Chesebro JH (1991): The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 310-318.
12. Gonçalves de Lima O, De Méllo JF, De Barros Coêlho JS, De Andrade Lyra FD, Machado de Albuquerque M, Marini-Bettólo GB, Delle Monache G, Delle Monache F (1975): New prenylated chalcones from Lonchocarpus neuroscapha Benth. (Cordoa piaca). Farmaco [Sci] 30: 326-342.
13. Hamberg M, Svenson J, Samuelsson B (1975): Thromboxane: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994-2995.
14. Harborne JB, Williams CA (2000): Advances in flavonoid research since 1992. Phytochemistry 55: 481-504.
15. Hayashi A, Gillen AC, Lott JR (2000): Effects of daily oral administration of quercetin chalcone and modified citrus pectin. Altern Med Rev 5: 546-552.
16. Herencia F, Ferrandiz ML, Ubeda A, Guillen I, Dominguez JN, Charris JE, Lobo GM, Lebeau J, Furman C, Bernier J, Duriez P, Teissier E, Cotelle N (2001): Antioxidant properties of di-tert-butylhydroxylated flavonoids. Free Radic Biol Med 29: 900-912.
17. Herman, AG (1998): Rationale for the combination of anti-aggregating drugs. Thromb Res 92: S17-S21.
18. Herstrup K, Jablonka B, Honig-Liedl P, Just M, Kochsiek K (1994): Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser 157 in human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem 225: 21-27.
19. Hjemdahl P, Chronos NAF, Wilson DJ, Bouyloux P, Goodall AH (1994): Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and p-selectin expression. Arterioscler Thromb 14: 77-84.
20. 2 production. Biochem Pharmacol 31: 1158-1160.
21. Hsieh HK, Tsao LT, Wang JP, Lin CN (2000): Synthesis and anti-inflammatory effect of chalcones. J Pharm Pharmacol 52: 163-171.
22. Kang WS, Lim IH, Yuk DY, Chung KH, Park JB, Yoo HS, Yun YP (1999): Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res 96: 229-237.
23. Liao CH, Tzeng CC, Teng CM (1998): Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent 6-[(3-methylene-2-oxo-5- phenyl-5-tetrahydrofuranyl) methoxy] quinolinone (CCT-62). Eur J pharmacol 349: 107-114.
24. Lin CN, Lee TH, Hsu MF, Wang JP, Ko FN, Teng CM (1997): 2′,5′-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. J Pharm Pharmacol 49: 530-536.
25. Lupi A, Delle Monache G, Delle Monache F, Marini-Bettólo GB, Gonçalves de Lima O, De Mello JF (1977): Synthetic analogs of natural prenylated and chromene chalcones. Farmaco [Sci] 32: 261-269.
26. Maurice DH, Haslam RJ (1990): Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 37: 671-681.
27. Moncada S, Higgs EA, Vane JR (1977): Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 309: 18-20.
28. 2 and prostacyclin. Pharmacol Rev 30: 293-331.
29. 2-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine. Thromb Res 99: 231-237.
30. Ohba Y, Soda K, Zaitsu K (2001): A sensitive assay of human blood platelet cyclic nucleotide phosphodiesterase activity by HPLC using fluorescence derivatization and its application to assessment of cyclic nucleotide phosphodiesterase inhibitors. Biol Pharm Bull 24: 567-569.
31. Pereira AS, Afonso Serrano MA, Aquino Neto FR, Cunha Pinto A, Furtado Teixeira D, Gilbert B (2000): Analysis and quantification of rotenoids and flavonoids in Derris (Lonchocarpus urucu) by high-temperature high-resolution gas chromatography. J Chromatogr Sci 38: 174-180.
32. Radomski MW, Moncada S (1993): The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol 344: 251-264.
33. Radomski MW, Palmer RM, Moncada S (1987): Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 7: 1057-1058.
34. Ross R (1990): The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature 362: 801-809.
35. Sidorova LD, Domnikova NP, Logvinenko AS (1991): [Platelet aggregation inhibitors in the comprehensive treatment of bronchial asthma]. Klin Med 69: 47-49.
36. Sousa MF, Cunha GMA, Fontenele JB, Viana GSB, Rao VSN (1994): Antithrombotic activity of ternatin, a tetrametoxy flavone from Egletes Viscosa Less. Phytother Res 8: 478-481.
37. Tzeng SH, Ko WC, Ko FN, Teng CM (1991): Inhibition of platelet aggregation by some flavonoids. Thromb Res 64: 91-100.